My read is they got what they wanted including n for treatment and control group but ex removal of adrenal gland monitoring. Hence:
"These changes to the monitoring and mitigation were supported by clinical and nonclinical data generated by Paradigm in its clinical development programs to date. Paradigm intends to implement these changes and submit the updated protocol under the open IND"
My read is they got what they wanted including n for treatment...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.015(5.77%) |
Mkt cap ! $85.80M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.0¢ | 24.0¢ | $969.3K | 3.648M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 34182 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 24689 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |